Abstract
The kinetics of isomerization of cyclosporin A to isocyclosporin A were studied in various nonaqueous solvents as a function of temperature and added methanesulfonic acid. The rate of isomerization was found to be acid-catalyzed over the acid concentration range studied. The choice of organic solvent significantly altered the rate of isomerization. For a series of alcohols, the rate was enhanced with increasing dielectric constant of the media, however, this correlation did not hold upon introduction of the dipolar aprotic solvent, tetrahydrofuran. Conversion of cyclosporin A to isocyclosporin A in tetrahydrofuran was found to contain diminished side reactions as compared to alcoholic solvents. The rate of conversion of isocyclosporin A to cyclosporin A was determined in aqueous buffers as a function of pH, buffer concentration, and temperature. The rates of conversion were extremely rapid compared to the forward reaction. Based on the pH dependencies of dilute solution reactivities, isocyclosporin A displayed a kinetically generated pK a value of 6.9 for the secondary amine moiety. From pH 8 to pH 10 the pH–rate profile plot is linear, with a slope approximately equal to unity, indicating apparent hydroxide ion catalysis. The break in pH–rate profile suggests a change in the rate-determining step upon protonation of isocyclosporin A. The rate of isomerization in plasma was comparable with that found in a pH 7.4 buffer solution, indicating that plasma proteins do not significantly alter the isomerization kinetics of isocyclosporin A to cyclosporin A.
Similar content being viewed by others
REFERENCES
M. Allen and R. Wade. Synthesis of somatostatin analogs resistant to the action of trypsin. Int. J. Pept. Protein Res. 32:89–97 (1988).
H. Sham, C. Rempel, H. Stein, and J. Cohen. Potent human renin inhibitors containing novel small cyclic peptides and stale to chymotrypsin degradation. J. Chem. Soc. Chem. Commun. 666–667 (1990).
R. F. Nutt, C. Colton, D. F. Veber, E. L. Slater, and R. Saperstein. Somatostatin analogs with improved oral bioavailability. Klin. Wochenschr. 64:71–73 (1986).
M. C. Manning, K. Patel, and R. T. Borchardt. Stability of protein Pharmaceuticals. Pharm. Res. 6:903–918 (1989).
K. Han, C. Richard, and G. Biserte. Current development in chemical cleavage of proteins. Int. J. Biochem. 15:875–884 (1983).
D. F. Elliott. A search for specific chemical methods for fission of peptide bonds. Biochem. J. 50:542–550 (1952).
J. I. Harris, R. D. Cole, and N. G. Pon. The kinetic of acid hydrolysis of dipeptides. Biochem. J. 62:154–159 (1956).
R. G. Strickley, M. Brandl, K. W. Chan, K. Struab, and L. Gu. High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution. Pharm. Res. 7:530–536 (1990).
A. Rüegger, M. Kuhn, H. Lichti, H. Lossli, R. Huguenin, C. Quiquerez, and A. Von Wartburg. Cyclosporin A, a peptide metabolite from Trichderma polysporum, with remarkable immunosuppressive activity. Helv. Chim. Acta 59:1075–1093 (1976).
L. D. Bowers and S. E. Mathews. Investigation of the mechanism of peak broadening observed in the high-performance liquid chromatographic analysis of cyclosporin A. J. Chromatogr. 333:231–238 (1985).
M. Bergmann, E. Brand, and F. Weinmann. Z. Physiol. Chem. 131:1 (1923).
L. V. Pavlova and F. Yu. Rachinskii. Rearrangements connected with migration of acyl and certain other groups. Russ. Chem. Rev. 37:587–602 (1968).
P. Desnuelle and A. Casal. Biochim. Biophys. Acta 2:64–75 (1948).
R. A. Fois and J. J. Ashley. Synthesis of a fluorescent derivative of cyclosporin A for high-performance liquid chromatography analysis. 80:363–367 (1991).
O. Popovych and R. P. T. Tomkins. Nonaqueous Solution Chemistry, Wiley-Interscience, New York, 1981.
N. S. Isaacs. Physical Organic Chemistry, Wiley-Interscience, New York, 1987.
M. Auriel and E. de Hoffmann. Quantitative study of solvent effects on Menshutkin reaction between 1,4-diazabicyclo-[2.2.2]octane and (2-chloroethyl)benzene, (2-bromoethyl)benzene, and (2-iodoethyl)benzene. J. Am. Chem. Soc. 97:7433–7437 (1975).
H. Bundgaard, C. Larsen, and E. Arnold. Prodrugs as drug delivery systems XXVII. Chemical stability and bioavailability of water-soluble prodrug of metronidazole for parenteral administration. Int. J. Pharm. 18:79–87 (1984).
A. C. Satterthwait and W. P. Jencks. The mechanism for aminolysis of acetate esters. J. Am. Chem. Soc. 96:7018–7031 (1974).
W. P. Jencks. Catalysis in Enzyme Chemistry and Enzymology, Dover, New York, 1987.
C. Weber, G. Wider, B. von Freyberg, R. Traber, W. Braun, H. Widmer, and K. Wüthrich. The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. Biochemistry 30:6563–6574 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oliyai, R., Stella, V.J. Kinetics and Mechanism of Isomerization of Cyclosporin A. Pharm Res 9, 617–622 (1992). https://doi.org/10.1023/A:1015841824760
Issue Date:
DOI: https://doi.org/10.1023/A:1015841824760